Biotech
KING OF PRUSSIA, PA: Phase 2 Clinical Study in Friedreich's Ataxia Patients Shows Strong Efficacy Signal; Management Estimates Peak Net Sales Potential for ACTIMMUNE of $500 Million With FA Approval ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 10/13/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced initiation of a phase 1/2 clinical trial to assess the safety and preliminary efficacy of ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwired) -- 10/09/14 -- Alchemia Limited (ASX: ACL)Alchemia Limited (ASX: ACL), a drug discovery and development company, announced today the database lock for the primary ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/09/14 -- Biosenta Inc. ("Biosenta" or the "Company") listed on the CNSX (CNSX: ZRO) is pleased to announce that Dene Rogers has been appoi ...
VANCOUVER, BRITISH COLUMBIA: Added Resources Build on Expertise and Reduce Drug Development Life Cycle as Company Continues Significant Development of Its Kinase Programs ...
SAN DIEGO, CA: Cell Therapy and Gene Silencing Combined for New Treatment of Advanced Breast Cancer Anticipated Clinical Trials to Validate dCellVax Platform, Allow for Expansion Into Other Cancers dCellVax Can Be I ...
MANCHESTER, NH: Increases Number of Medical Advisory Board Members to Eight ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/08/14 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2014.Third quarter ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 10/07/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Dino Dina, M.D, has resigned from the Board of Directors. Dr. Dina was a director of ...
MANCHESTER, NH: Application Inspired by Recently Discovered Mechanism of Action of BTI-320 ...
LONDON, ONTARIO: Significant Impact of COTI-2's p53-dependent Mechanism of Action on Cancer to Be Highlighted ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 10/06/14 -- Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE: IMV), a clinical stage vaccine and imm ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 10/06/14 -- Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 13th Annual BIO Investor ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 10/06/14 -- Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE: IMV), a clinical stage vaccine and imm ...
TUSTIN, CA: UTSW Collaborators Found Phosphatidylserine (PS)-Targeting Antibody in Combination With an Anti-PD-1 or an Anti-CTLA-4 Immune Checkpoint Inhibitor Promotes a Robust, and Localized Anti-Tumor Response ...
NEWARK, DE: NEWARK, DE -- (Marketwired) -- 10/03/14 -- iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required by ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 10/03/14 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
